Regulation costs account for 90% of bringing a drug to market, on average $1 billion and 10 years of clinical trials for each new drug [1]. Of course, a mere 10

Regulation costs account for 90% of bringing a drug to market, on average $1 billion and 10 years of clinical trials for each new drug [1]. Of course, a mere 10 years of clinical trial cannot catch all long-term side effects, and we would be safer if the FDA was more stringent. The flip side is that we would have fewer and more expensive health care options. For better or worse, our regulatory structure is heavily biased towards fewer deaths from approved treatments, very long clinical trials, and expensive health care. In general, the word "agile" and the health industry have nothing to do with each other. [1] yeah, yeah, citation needed. I pick facts up by listening to The Economist podcast on the way home, you go find a hyperlink.